Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge

Stimulation of the Larynx to Treat Unexplained Chronic Cough

NCT05273190 ·Status: RECRUITING ·Phase: NA

A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers

NCT01661244 ·Status: COMPLETED ·Phase: PHASE1

A Multiple-Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of HS-10383

NCT06092983 ·Status: UNKNOWN ·Phase: PHASE1

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

NCT05660850 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD)

NCT01842360 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

NCT02993822 ·Status: COMPLETED ·Phase: PHASE2

A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function

NCT05570981 ·Status: UNKNOWN

A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

NCT06213363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers

NCT01818024 ·Status: COMPLETED ·Phase: PHASE1

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

NCT01857323 ·Status: COMPLETED ·Phase: PHASE3

Exhaled Breath Aerosol for the Etiological Diagnosis of Respiratory Tract Infections: a Pilot Study

NCT06229613 ·Status: COMPLETED

Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma

NCT04576325 ·Status: COMPLETED ·Phase: PHASE1

Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

NCT04901455 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Evaluation of Treatments for Dry or Productive Cough

NCT07330856 ·Status: RECRUITING ·Phase: PHASE4

Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175

NCT05628740 ·Status: COMPLETED ·Phase: PHASE1

Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD

NCT06841640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Inhaled XQ-001 in Healthy Subjects

NCT06918366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation

NCT04656275 ·Status: TERMINATED ·Phase: PHASE1

Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia

NCT04738136 ·Status: SUSPENDED ·Phase: PHASE2

Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

NCT02172521 ·Status: COMPLETED

A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

NCT00784550 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough

NCT05733533 ·Status: COMPLETED ·Phase: PHASE2

Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities

NCT00621582 ·Status: COMPLETED

Study of Biomarkers of Airway Inflammation (0000-128)

NCT00869596 ·Status: COMPLETED ·Phase: PHASE1

Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects

NCT02341183 ·Status: WITHDRAWN ·Phase: NA